Search Results - Virginia Arrazubi

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma by Ibone Labiano, Ana E. Huerta, Maria Alsina, Hugo Arasanz, Natalia Castro, Saioa Mendaza, Arturo Lecumberri, Iranzu Gonzalez-Borja, David Guerrero-Setas, Ana Patiño-Garcia, Gorka Alkorta-Aranburu, Irene Hernández-Garcia, Virginia Arrazubi, Elena Mata, David Gomez, Antonio Viudez, Ruth Vera

    Published in Scientific Reports (2024-07-01)
    Get full text
    Article


  2. 2

    Low rather than high interleukin-6 levels are associated with immune-related adverse events in cancer patients treated with immune checkpoint inhibitors by Iñigo Les, Iñigo Les, Iñigo Les, David de Haedo, David de Haedo, David de Haedo, Mireia Martínez, Mireia Martínez, Berta Ibáñez-Beroiz, Berta Ibáñez-Beroiz, Amaia Moreno, Ibone de Elejoste, Ana Campillo-Calatayud, Inés Pérez-Francisco, María Cabero, Iñaki Elejalde, Iñaki Elejalde, Iñaki Elejalde, Virginia Arrazubi

    Published in Frontiers in Immunology (2025-09-01)
    Get full text
    Article


  3. 3

    Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSE... by Manuel Sánchez-Cánovas, Paula Jimenez-Fonseca, David Fernández Garay, Mónica Cejuela Solís, Diego Casado Elía, Eva Coma Salvans, Irma de la Haba Vacas, David Gómez Sánchez, Ana Fernández Montés, Roberto Morales Giménez, Mercedes Biosca Gómez de Tejada, Virginia Arrazubi Arrula, Silvia Sequero López, Remedios Otero Candelera, Cristina Sánchez Cendra, Marina Justo de la Peña, Diana Moreno Muñoz, Mayra Orillo Sarmiento, Eva Martínez de Castro, Ignacio García Escobar, Alejandro Bernal Vidal, Laura Ortega Moran, Andrés J Muñoz Martín, Rodrigo Sánchez Bayona, María José Martínez Ortiz, Francisco Ayala de la Peña, Vicente Vicente, Alberto Carmona-Bayonas

    Published in PLoS ONE (2023-01-01)
    Get full text
    Article


  4. 4

    The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy by Paula Jimenez-Fonseca, Victoria Foy, Sophie Raby, Alberto Carmona-Bayonas, Lola Macía-Rivas, Virginia Arrazubi, Diego Cacho Lavin, Raquel Hernandez San Gil, Ana Custodio, Juana María Cano, Ana Fernández Montes, Oriol Mirallas, Ismael Macias Declara, Rosario Vidal Tocino, Laura Visa, María Luisa Limón, Paola Pimentel, Nieves Martínez Lago, Tamara Sauri, Marta Martín Richard, Monserrat Mangas, Mireia Gil Raga, Aitana Calvo, Pablo Reguera, Mónica Granja, Alfonso Martín Carnicero, Carolina Hernández Pérez, Paula Cerdá, Lucía Gomez Gonzalez, Francisco Garcia Navalon, Vilma Pacheco Barcia, David Gutierrez Abad, Maribel Ruiz Martín, Jamie Weaver, Wasat Mansoor, Javier Gallego

    Published in Therapeutic Advances in Medical Oncology (2023-03-01)
    Get full text
    Article


Search Tools: